Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Stock Movers: Agios Pharma, Rivian, Fiserv
Stock Movers: Agios Pharma, Rivian, Fiserv
Bloomberg

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…

newswire.ca - Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
CNW

EAST RUTHERFORD, N.J., July 7, 2026 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the…

thehindubusinessline.com - Marksans Pharma to acquire Germany-based ABCnow GmbH
Marksans Pharma to acquire Germany-based ABCnow GmbH
BusinessLine

Marksans Pharma Ltd on Wednesday said it will acquire Germany-based pharmaceutical wholesale and distributor ABCnow GmbH for euro 8,92,384 (nearly ₹10 crore). The company has entered into a definitive agreement to acquire 100 per cent of the…

thehindubusinessline.com - Broker's Call: Mankind Pharma (Add)
Broker's Call: Mankind Pharma (Add)
BusinessLine

After years of growth led by distribution reach and prescription volume, Mankind Pharma is re-orienting towards research-led, niche and specialty therapies where competition is thinner. A calculated move into low-competition specialty niches is a…

thehindubusinessline.com - Natco Pharma to raise stake in Adcock Ingram to 49% with ₹1,400 crore investment
Natco Pharma to raise stake in Adcock Ingram to 49% with ₹1,400 crore investment
BusinessLine

The board of directors of Natco Pharma has approved the acquisition of an additional shareholding in Adcock Ingram Holdings Proprietary Ltd with an investment of up to ₹1400 crore. This acquisition is valued at ₹1,069 crore at the…

newswire.ca - Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
CNW

MUMBAI, India, July 7, 2026 /CNW/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global…

thehindubusinessline.com - Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger
Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger
BusinessLine

Shares of Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals surged to fresh 52-week highs on Tuesday after the National Company Law Tribunal's Ahmedabad Bench sanctioned the merger of JB Chemicals into Torrent Pharmaceuticals on Monday…

rediff.com - Nandita Malik - Indian Stock Markets Tumble Amid US-Iran Tensions, Rising Crude Oil Prices
Indian Stock Markets Tumble Amid US-Iran Tensions, Rising Crude Oil Prices
Rediff.com

Indian stock markets, including the Sensex and Nifty, witnessed a sharp decline in early trading as renewed US-Iran tensions and a significant spike in crude oil prices created a climate of uncertainty for investors. Indian benchmark indices…

indianexpress.com - Express Web Desk - Sensex falls 1,700 points as Trump's latest Iran outburst rattles global markets
Sensex falls 1,700 points as Trump's latest Iran outburst rattles global markets
The Indian Express

Indian equity markets saw a sharp sell-off on Wednesday, with the benchmark Sensex and Nifty 50 tumbling as investors reacted to escalating tensions in West Asia. Market sentiments weakened after the US military launched attacks on Iran, claiming…

forbes.com - Kamya Elawadhi - Five Ways AI Is Transforming Healthcare Marketing
Five Ways AI Is Transforming Healthcare Marketing
Forbes

Kamya Elawadhi is Co-Founder and President at Doceree. Healthcare marketing has always been complex. The audiences are more specialized than in almost any other industry, every interaction lives inside a strict regulatory environment and the…

investors.com - ALLISON GATLIN - Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Investor's Business Daily

Eli Lilly (LLY) shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill. Kailera's partner, Hengrui Pharma, ran two studies in patients in China. But the results seemingly paled…

globenewswire.com - Biocartis NV - Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
GlobeNewswire

PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics ITASCA, IL, US and HUNTSVILLE, AL, US – July 07, 2026. Today, Biocartis, an…

thehindu.com - Pti - Stock markets decline in early trade on renewed U.S.-Iran tensions, spike in crude oil prices
Stock markets decline in early trade on renewed U.S.-Iran tensions, spike in crude oil prices
The Hindu

Benchmark indices Sensex and Nifty tumbled in early trade on Wednesday (July 8, 2026) amid renewed U.S.-Iran tensions and a fresh spike in crude oil prices. The 30-share BSE Sensex tanked 537.83 points to 77,642.89 in early trade. The 50-share NSE…

forbes.com - Bruce Japsen - Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock's Asembia Buy
Forbes

News The Cigna Group's Evenorth health services business has committed $100 million to support a new artificial intelligence-powered pharmacy program and a private equity firm's purchase of Asembia are only the latest in a wave of huge investments…

bbc.co.uk - Nikhil Inamdar - Philanthropy: From temples to technology - India's wealthy are finally giving to science - India's wealthy are finally giving to science
Philanthropy: From temples to technology - India's wealthy are finally giving to science - India's wealthy are finally giving to science
BBC

Last year, Indian-American physicist Jainendra Jain, a co-recipient of the prestigious 2025 Wolf Prize and a figure well-known for his revolutionary research in quantum physics, was taken aback when he received a call from an Indian real estate…

Receive a Daily briefing on Pharma Industry News

Get Started